Javascript must be enabled to continue!
Interaction of heparin with internally quenched fluorogenic peptides derived from heparin-binding consensus sequences, kallistatin and anti-thrombin III
View through CrossRef
Internally quenched fluorogenic (IQF) peptides bearing the fluorescence donor/acceptor pair o-aminobenzoic acid (Abz)/N-(2,4-dinitrophenyl)ethylenediamine (EDDnp) at N- and C-terminal ends were synthesized containing heparin-binding sites from the human serpins kallistatin and antithrombin, as well as consensus heparin-binding sequences (Cardin clusters). The dissociation constant (Kd), as well as the stoichiometry for the heparin–peptide complexes, was determined directly by measuring the decrease in fluorescence of the peptide solution. Experimental procedures were as sensitive as those used to follow the fluorescence change of tryptophan in heparin-binding proteins. The conformation of the peptides and the heparin–peptide complexes were obtained from measurements of time-resolved fluorescence decay and CD spectra. Kallistatin (Arg300–Pro319)-derived peptide (HC2) and one derived from antithrombin III helix D [(AT3D), corresponding to Ser112–Lys139], which are the heparin-binding sites in these serpins, showed significant affinity for 4500Da heparin, for which Kd values were 17nM and 100nM respectively. The CD spectra of the heparin–HC2 peptide complex did not show any significant α-helix content, different from the situation with peptide AT3D, for which complex-formation with heparin resulted in 24% α-helix content. The end-to-end distance distribution and the time-resolved fluorescence-decay measurements agree with the CD spectra and Kd values. The synthetic α-methyl glycoside pentasaccharide AGA∗IAM (where A represents N,6-O-sulphated α-d-glucosamine; G, β-d-glucuronic acid; A∗, N,3,6-O-sulphated α-d-glucosamine; I, 2-O-sulphated α-l-iduronic acid; and AM, α-methyl glycoside of A) also binds to AT3D and other consensus heparin-binding sequences, although with lower affinity. The interaction of IQF peptides with 4500Da heparin was displaced by protamine. In conclusion, IQF peptides containing Abz/EDDnp as the donor/acceptor fluorescence pair are very promising tools for structure–activity relationship studies on heparin–peptide complexes, as well as for the development of new peptides as heparin reversal-effect compounds.
Title: Interaction of heparin with internally quenched fluorogenic peptides derived from heparin-binding consensus sequences, kallistatin and anti-thrombin III
Description:
Internally quenched fluorogenic (IQF) peptides bearing the fluorescence donor/acceptor pair o-aminobenzoic acid (Abz)/N-(2,4-dinitrophenyl)ethylenediamine (EDDnp) at N- and C-terminal ends were synthesized containing heparin-binding sites from the human serpins kallistatin and antithrombin, as well as consensus heparin-binding sequences (Cardin clusters).
The dissociation constant (Kd), as well as the stoichiometry for the heparin–peptide complexes, was determined directly by measuring the decrease in fluorescence of the peptide solution.
Experimental procedures were as sensitive as those used to follow the fluorescence change of tryptophan in heparin-binding proteins.
The conformation of the peptides and the heparin–peptide complexes were obtained from measurements of time-resolved fluorescence decay and CD spectra.
Kallistatin (Arg300–Pro319)-derived peptide (HC2) and one derived from antithrombin III helix D [(AT3D), corresponding to Ser112–Lys139], which are the heparin-binding sites in these serpins, showed significant affinity for 4500Da heparin, for which Kd values were 17nM and 100nM respectively.
The CD spectra of the heparin–HC2 peptide complex did not show any significant α-helix content, different from the situation with peptide AT3D, for which complex-formation with heparin resulted in 24% α-helix content.
The end-to-end distance distribution and the time-resolved fluorescence-decay measurements agree with the CD spectra and Kd values.
The synthetic α-methyl glycoside pentasaccharide AGA∗IAM (where A represents N,6-O-sulphated α-d-glucosamine; G, β-d-glucuronic acid; A∗, N,3,6-O-sulphated α-d-glucosamine; I, 2-O-sulphated α-l-iduronic acid; and AM, α-methyl glycoside of A) also binds to AT3D and other consensus heparin-binding sequences, although with lower affinity.
The interaction of IQF peptides with 4500Da heparin was displaced by protamine.
In conclusion, IQF peptides containing Abz/EDDnp as the donor/acceptor fluorescence pair are very promising tools for structure–activity relationship studies on heparin–peptide complexes, as well as for the development of new peptides as heparin reversal-effect compounds.
Related Results
Kallistatin Inhibits Vascular Inflammation by Antagonizing Tumor Necrosis Factor-α–Induced Nuclear Factor κB Activation
Kallistatin Inhibits Vascular Inflammation by Antagonizing Tumor Necrosis Factor-α–Induced Nuclear Factor κB Activation
Kallistatin is a plasma protein with anti-inflammatory properties. In this study, we investigated the role and mechanisms of kallistatin in inhibiting endothelial inflammation thro...
Kallistatin treatment attenuates lethality and organ injury in mouse models of established sepsis
Kallistatin treatment attenuates lethality and organ injury in mouse models of established sepsis
Abstract
Introduction
Kallistatin levels in the circulation are reduced in patients with sepsis and liver disease. Transgenic mice expressing kallis...
Kallistatin: double-edged role in angiogenesis, apoptosis and oxidative stress
Kallistatin: double-edged role in angiogenesis, apoptosis and oxidative stress
AbstractKallistatin, via its two structural elements – an active site and a heparin-binding domain – displays a double-edged function in angiogenesis, apoptosis and oxidative stres...
Reduced Plasma Kallistatin Is Associated With the Severity of Coronary Artery Disease, and Kallistatin Treatment Attenuates Atherosclerotic Plaque Formation in Mice
Reduced Plasma Kallistatin Is Associated With the Severity of Coronary Artery Disease, and Kallistatin Treatment Attenuates Atherosclerotic Plaque Formation in Mice
Background
Kallistatin exerts beneficial effects on organ injury by inhibiting oxidative stress and inflammation. However, the role of kallistatin in ath...
Plasma kallistatin levels in patients with severe community-acquired pneumonia
Plasma kallistatin levels in patients with severe community-acquired pneumonia
Abstract
Introduction
Community-acquired pneumonia (CAP) requiring intensive care unit (ICU) treatment commonly causes acute respira...
Thrombin interaction with platelet glycoprotein Ib: effect of glycocalicin on thrombin specificity
Thrombin interaction with platelet glycoprotein Ib: effect of glycocalicin on thrombin specificity
We describe here the alteration of thrombin specificity induced by its interaction with glycocalicin. Glycocalicin is the external part of platelet glycoprotein Ib alpha (GPIb alph...
Interaction of Thrombin with Antithrombin III and α2Macrogeobulin
Interaction of Thrombin with Antithrombin III and α2Macrogeobulin
When one unit of thrombin was added to recalcified diluted plasma, more thrombin activity was shown in the presence of heparin than in its absence, but no difference was shown afte...
Salutary Effect of Kallistatin in Salt-Induced Renal Injury, Inflammation, and Fibrosis via Antioxidative Stress
Salutary Effect of Kallistatin in Salt-Induced Renal Injury, Inflammation, and Fibrosis via Antioxidative Stress
An inverse relationship exists between kallistatin levels and salt-induced oxidative stress in Dahl-salt sensitive rats. We further investigated the role of kallistatin in inhibiti...

